-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

506. Bone Marrow Microenvironment: Poster III

Symposia: Bone Marrow Microenvironment Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Charles Bataclan1*, Wangjie Liu2*, Benoit Von der Weid, PhD1,2*, Silvia Vaz Ferreira Lopes1*, Rita Sarkis, PhD3*, Jessica Sordet-Dessimoz, PhD4*, Mariangela Constanza, MD5*, Olivier Spertini, MD5, Sabine Blum, MD5*, Laurence de Leval, MD, PhD3, Stéphane Cherix, MD6*, Bart Deplancke, PhD2* and Olaia Naveiras, MD, PhD1,5

1Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland
2Institute of Bioengineering, École polytechnique fédérale de Lausanne, Lausanne, Switzerland
3Department of Pathology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
4Histlogy Core Facility, École polytechnique fédérale de Lausanne, Lausanne, Switzerland
5Hematology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
6Department of Orthopedic Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

Elizabeth K Schweighart1,2*, Cristoforo Grasso2*, Brigit M. te Pas2*, Mirjam E. Belderbos, MD, PhD2, Christian Michel Zwaan, MD2,3, Hendrik G. Stunnenberg, PhD2,4*, Olaf Heidenreich, PhD2,5 and Bianca F. Goemans, MD, PhD2

1Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, Utrecht, Netherlands
2Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
3Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
4Nijmegen Centre For Molecular Life Sciences, Nijmegen, Netherlands
5Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, United Kingdom

Alejandro De Janon, MSc1,2, Pranitha Kaza3*, Deborah DeRyckere, PhD2, Douglas K. Graham, MD2 and Shuichi Takayama, PhD4*

1W. H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA
2Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta, and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
3W. H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA
4Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine, Atlanta, GA

Sadhna O Piryani, BS1*, Elizabeth Fan, BS1*, Angel Kam, PhD2*, Yiqun Jiao2*, Nelson J. Chao, MD3, Phuong Linh Doan, MD4* and Benny J. Chen, MD5

1Medicine, Duke University Medical Center, Durham, NC
2Duke University, Durham, NC
3Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, NC
4Duke University Medical Center, Durham, NC
5Duke Univ. Medical Center, Durham, NC

Rong Xin Liu1*, Meizhang Li, PhD2*, Harsh B. Pathak, PhD2*, Tara L. Lin, MD3,4, Barry S. Skikne, MD3,4*, Joseph P. McGuirk, DO3,5, Omar Aljitawi, MD6, Andrew K. Godwin, PhD2,3* and Haitham Abdelhakim, MD3,7

1School of Pharmacy, University of Kansas, Leavenworth, KS
2Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS
3University of Kansas Cancer Center, Kansas City, KS
4Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Ctr., Westwood, KS
6Division of Hematology/Oncology and Bone Marrow Transplantation Program, University of Rochester Medical Center, Rochester, NY
7Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS

Wantong Li1, Konur Oyman, MSc2*, Annika Chura1* and Bradley Wayne Blaser, MD, PhD3

1Division of Hematology, The Ohio State University, Columbus, OH
2Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

Annika Chura1*, Wantong Li2, Konur Oyman, MSc1*, Victoria Wang, MD, PhD3* and Bradley Wayne Blaser, MD, PhD1

1Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3University of California, San Francisco, San Francisco, CA

Jenna S Sneifer, BA1*, Jessica Pham, BS2*, Inge Van Der Werf2*, Larissa Balaian, PhD2*, Emma E Klacking, BS2*, Neha Katragadda, BS2*, Luisa Ladel, MD3*, Anna Kulidjian, MD4*, Patrick Chang, PhD, MS5*, Thomas Whisenant, PhD6* and Catriona Jamieson, MD, PhD7

1Division of Regenerative Medicine, UC San Diego, La Jolla, CA
2Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UCSD, La Jolla, CA
3Yale University, New Haven, CT
4Scripps Health, La Jolla, CA
5Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UC San Diego, La Jolla, CA
6Center for Computational Biology and Bioinformatics, UCSD, La Jolla, CA
7Sanford Stem Cell Institute, CIRM UC San Diego Alpha Stem Cell Clinic, La Jolla, CA

Ding-Wen Chen, PhD1, Eric K. Wafula, PhD2*, Julie M. Schrey, BSc1*, Jian-Meng Fan, BSc1*, Sarah Adams, BS3*, Seul K Jung, BS4*, Deanne M Taylor, PhD2* and Peter Kurre, MD5

1Comprehensive Bone Marrow Failure Center, Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
3Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Cell & Molecular Biology Graduate Group, University of Pennsylvania, Philadelphia, PA
5Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA

Alba Ferrer, PhD1,2*, Rebecca Andersson, PhD3*, Polina Zjablovskaja, PhD4*, Francesca Matteini, PhD5,6*, Eva Mejia-Ramirez, PhD1,6*, Javier Lozano, PhD1,6*, Sara Montserrat-Vazquez6,7*, Gina Marka8*, Medhanie Assmelash Mulaw, Jun.-Prof.9* and Maria Carolina Florian, PhD10*

1Stem Cell Aging Group, Regenerative Medicine Program, The Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Spain
2The Bellvitge Institute For Biomedical Research (IDIBELL), L'Hospitalet De Llobregat, Spain
3Program of Regenerative Medicine, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet De Llobregat, AL, ESP
4Unit for single-cell Genomics, Ulm University, Ulm, Germany
5Stem Cell Aging Group, Regenerative Medicine Program, The Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet De Llobregat (barcelona), ESP
6Program for Advancing the Clinical Translation of Regenerative Medicine of Catalonia, P-CMR[C], L'Hospitalet de Llobregat, Spain
7Stem Cell Aging Group, Regenerative Medicine Program, The Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet De Llobregat, ESP
8Institute of Molecular Medicine, Ulm University, Ulm, DEU
9Unit for single-cell genomics, Medical faculty Ulm, Ulm, Germany
10Program of Regenerative Medicine, Bellvitge Institute for Biomedical Research, Barcelona, Spain

*signifies non-member of ASH